Stocks of several companies jumped significantly today due to key corporate developments. STAK Inc. led with a 596% rise after announcing a U.S. subsidiary to develop power systems for AI data centers, highlighting investor interest in AI infrastructure. Scribe Therapeutics made a strong IPO debut, rising over 46%, signaling confidence in its genetic medicine technology. RingCentral gained 25% following better-than-expected earnings driven by subscription growth and AI tool adoption. These moves reflect strong market enthusiasm for AI and strategic corporate actions.
Baker Hughes Company is set to report its Q2 2026 earnings with analysts forecasting EPS between $0.49 and $0.51 and revenue around $6.49 to $6.51 billion, both reflecting a year-over-year decline. Despite this, the company has a solid track record o...
Faraday Future Intelligent Electric Inc. saw its stock drop nearly 40% despite recent product showcases, indicating investor worries beyond its new offerings. Zevra Therapeutics' shares fell almost 24% after the European Medicines Agency issued a neg...
NovaBridge Biosciences announced its annual general meeting (AGM) will be held on September 8, 2026, in Shanghai. The company is advancing clinical-stage biopharmaceutical treatments, including givastomig for gastric cancer and VIS-101 for retinal di...
Pelthos Therapeutics announced its 2026 Annual Meeting of Stockholders will be held virtually on September 29, 2026, at 9:00 a.m. Eastern Time. Stockholders of record as of August 4, 2026, are eligible to vote. The company will file the official noti...
Mdxhealth announced it received a Nasdaq notification for failing to meet the minimum market value of listed securities requirement of $35 million. The company has 180 days, until January 19, 2027, to regain compliance by exceeding this market value ...
